Fangjian Guo

Fangjian Guo, MD, PhD, serves as Assistant Professor in the Department of Obstetrics & Gynecology at the University of Texas Medical Branch (UTMB). His research centers on cancer epidemiology within women's health, with emphasis on gynecologic malignancies and preventive strategies across the lifespan.

His primary research domains include cancer epidemiology, gynecologic oncology, and preventive medicine. Key investigations examine endometrial and ovarian cancer trends by menopausal status, HPV vaccination impact, tobacco-related cancer mortality, and healthcare delivery for immunocompromised women. His work integrates population-level data with clinical prevention frameworks to address health disparities.

Recent publications demonstrate consistent output in high-impact journals like Cancers and Cancer Epidemiology, Biomarkers and Prevention. His research portfolio shows strong focus on cancer incidence/mortality trends (particularly uterine and ovarian cancers), preventive interventions in special populations, and health services research. Temporal analysis reveals increasing emphasis on cost-effectiveness studies alongside traditional epidemiological investigations.

Dr. Guo serves as Principal Investigator on National Cancer Institute grant #5K07CA22234305 (Genetic testing in young women for cancer prevention, 2018-2023). While specific advisees aren't listed, his faculty role involves mentoring medical students and residents. His publication record shows extensive collaboration with UTMB colleagues including Berenson, Adekanmbi, and Hoang across multi-institutional teams.

Research activities involve interdisciplinary collaboration networks spanning epidemiology, oncology, and public health departments. Current work focuses on cancer prevention strategies through genetic testing and vaccination programs, with emerging interest in surgical preparedness optimization and health economics.